Golgiplex accelerates Biotech startups & Labs by connecting you with top-tier consultants for Pre-IND strategy, Regulatory Affairs, Grant Writing, and Computational Biology.
FDA Pre-IND strategy, 505(b)(2) analysis, and compliance pathways.
SBIR/STTR Phase I/II, NIH, and Foundation grant proposal development.
CMC strategy, toxicology study design, and clinical development planning.
Genomics analysis, AI-driven drug discovery, and bioinformatics pipelines.
See how Golgiplex transforms the trajectory of scientific startups.
Founders pitch to VCs early but face competition and high burn rates.
Outcome: Cash burn, missed milestones, failure before IND.
Strategic planning using non-dilutive grants and project-based experts.
Total Investment
$45-70K
Result
IND-Ready + $1.2M Grants
Founders build great AI but underestimate SaMD regulations and reimbursement.
Outcome: Great tech, no business model. Runs out of funds.
Simultaneous FDA submission track, clinical validation, and market access work.
Total Investment
$45-70K
Result
Validation + Series A ($5-8M)
Tell us about your project needs. We'll connect you with the right experts.
Request Received!
We will contact you shortly.
Are you a specialized consultant in Regulatory Affairs, Comp Bio, or Grant Writing? Join the Golgiplex network to access vetted high-impact projects.
Opens in external window